ProCE Banner Activity

Next-Generation HER2-Directed ADCs in Development

Slideset Download

Download this slideset to review the latest data on next generation antibody drug conjugates in breast cancer.

Released: October 30, 2020

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Ian Krop, MD, PhD

Professor of Internal Medicine
Associate Cancer Center Director for Clinical Research
Chief Clinical Research Officer
Yale Cancer Center
New Haven, Connecticut

Ian Krop, MD, PhD: consultant/advisor/speaker: ALX Oncology, AstraZeneca, Daiichi Sankyo, EMD Serono, Genentech/Roche, Novartis, Ottimo, Pfizer, Seagen.